Immunovant’s first-generation FcRn inhibitor flunked a pair of phase 3 eye disease trials, appearing to end the last hopes of ...

When Aardvark Therapeutics announced earlier this month that it was pausing a phase 3 trial of its lead metabolic candidate, ...

"Ayahuasca-derived DMT study shows positive effects on depression therapy in trials" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...

Tech giants boast massive wealth and a track record of weathering attacks in Congress and the courts, but two jury verdicts ...

It’s a well-known fact for anyone who has ever tried navigating the world of cancer clinical trials: Finding a research trial that’s a match for you isn’t easy. “It’s a kind of Wild West out there,” ...

Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.

Clinical trials are widely accepted as the way to progress toward establishing new standards in cancer therapies while simultaneously offering affordable, state-of-the-art care. But few people ...